Biogen Pharmachem Industries Ltd has announced a bonus share issue in the ratio of 1:6, signaling strong shareholder rewards. The board also approved an increase in authorized share capital and appointed new statutory auditors, with all decisions subject to shareholder approval via postal ballot.
Biogen Pharmachem Industries Ltd, held its board meeting on March 23, 2026. The company has recommended issuing fully paid-up bonus shares, alongside key corporate actions to strengthen its capital structure and governance.
Bonus Share Announcement
The board approved a bonus issue of one equity share for every six held, amounting to 15.04 crore new shares. These will be issued from the securities premium account, ensuring no cash outflow. The record date will be announced later, and shares will be credited within two months.
Capital Restructuring
Authorized share capital will be raised from Rs. 91 crore to Rs. 108 crore, with amendments to the Memorandum of Association subject to shareholder approval.
Governance Updates
M/s. Goenka Mehta & Associates, Rajkot, have been appointed as statutory auditors following the resignation of the previous firm due to medical reasons.
Key Highlights
-
Bonus issue ratio 1:6
-
15.04 crore new equity shares to be issued
-
Capital raised to Rs. 108 crore
-
Bonus shares from securities premium reserves
-
New statutory auditors appointed
Sources: Company filing with BSE